The Nebulizer Kits industry trends over the past 18 months reveal a pivot toward digitally-connected, sustainability-focused care. In January 2024, Philips and Novo Nordisk formed a rare device-pharma alliance to co-develop Bluetooth-enabled nebulizer kits that log adherence data directly into electronic health records, a move expected to set new adherence benchmarks. April 2024 saw ResMed acquire Inogen’s nebulizer assets for $330 million, instantly widening ResMed’s home-respiratory footprint across Europe. Product launches have shifted to mesh-free, battery-agnostic platforms: PARI’s 2023 eFlow-Go Ultra cuts treatment time to 4 minutes while slashing plastic waste by 30%, and Omron’s 2024 MicroAir U200 uses recyclable cassettes—both reflecting tightening EU MDR lifecycle requirements that now demand recyclability impact statements. Enterprise demand is migrating from hospital purchasing groups to subscription models; Aerogen’s 2023 agreement with Cardinal Health delivers kits on a per-dose plan, trimming hospital inventory by 18%. Venture funding has concentrated on refillable reservoirs: BeyondAero closed a $26 million Series A in Q1 2024 for its aluminum-based SustainableKit, forecasting 50% cost savings for high-volume clinics. Meanwhile, U.S. CMS expanded reimbursement for at-home nebulizer kits under CPT 94642, accelerating retail channel uptake and prompting CVS Health to roll out private-label kits in 1,100 pharmacies last quarter.
